TABLE 1.
CHARACTERISTICS OF WOMEN UNDERGOING FERTILITY TREATMENT AND COVID-19-RELATED VARIABLES ACCORDING TO AGREEMENT WITH THE CFAS GUIDELINES AND WILLINGNESS TO RESUME TREATMENTS
| Socio-demographic and infertility characteristics | All | Agree with the CFAS guidelines | P-value | Willing to resume treatments | P-value | ||
|---|---|---|---|---|---|---|---|
| (n = 181) | No (n = 78) | Yes (n = 103) | No (n = 33) | Yes (n =148) | |||
| Age, yearsa, n (%) | 0.28 | 0.03 | |||||
| <35 | 40 (22) | 14 (18) | 26 (25) | 10 (30) | 30 (20) | ||
| 35–40 | 97 (54) | 47 (60) | 50 (49) | 11(33) | 86 (58) | ||
| ≥41 | 44 (24) | 17 (22) | 27 (26) | 12 (36) | 32 (22) | ||
| Educationa, n (%) | 0.34 | 0.60 | |||||
| High School | 4 (2) | 3 (4) | 1 (1) | 1 (3) | 3 (2) | ||
| Community college | 23 (13) | 7 (9) | 16 (16) | 5 (15) | 18 (12) | ||
| Undergraduate | 65 (36) | 27 (35) | 38 (37) | 9 (27) | 56 (38) | ||
| Postgraduate | 89 (49) | 41 (53) | 48 (47) | 18 (55) | 71 (48) | ||
| Income, CADa, n (%) | 0.005 | 0.31 | |||||
| <109,999 | 51 (28) | 14 (18) | 37 (36) | 14 (42) | 37 (25) | ||
| ≥110,000 | 110 (61) | 56 (72) | 54 (52) | 17 (52) | 93 (63) | ||
| Prefer not to say | 20 (11) | 8 (10) | 12 (12) | 2 (6) | 18 (12) | ||
| Relationshipa, n (%) | 0.40 | 0.99 | |||||
| Single | 13 (7) | 4 (5) | 9 (9) | 2 (6) | 11 (7) | ||
| Has a partner | 168 (93) | 74 (95) | 94 (91) | 31 (94) | 137 (93) | ||
| Number of childrena, n (%) | 0.33 | 0.68 | |||||
| 0 | 127 (70) | 58 (74) | 69 (67) | 22 (67) | 105 (71) | ||
| ≥1 | 54 (30) | 20 (26) | 34 (33) | 11 (33) | 43 (29) | ||
| Religious, statusa, n (%) | 0.1 | 0.93 | |||||
| Religious | 78 (43) | 39 (50) | 39 (38) | 14 (42) | 64 (43) | ||
| No religion | 103 (57) | 39 (50) | 64 (62) | 19 (58) | 84 (57) | ||
| Occupation a, n (%) | 0.78 | 0.54 | |||||
| Health-related | 46 (25) | 19 (24) | 27 (26) | 7 (21) | 39 (26) | ||
| Other | 135 (75) | 59 (76) | 76 (74) | 26 (79) | 109 (74) | ||
| Ethnicitya, n (%) | 0.43 | 0.11 | |||||
| White | 115 (64) | 47 (60) | 68 (66) | 17 (52) | 98 (66) | ||
| Non-white | 66 (36) | 31 (40) | 35 (34) | 16 (48) | 50 (34) | ||
| Infertility diagnosisa, n (%) | 0.04 | 0.42 | |||||
| Female factor | 66 (36) | 35 (45) | 31 (30) | 10 (30) | 56 (38) | ||
| Other | 115 (64) | 43 (55) | 72 (70) | 23 (70) | 92 (62) | ||
| Fertility treatmenta, n (%) | 0.16 | 0.39 | |||||
| IUI or ovulation induction | 43 (24) | 15 (19) | 28 (27) | 6 (18) | 37 (25) | ||
| IVF | 74 (41) | 38 (49) | 36 (35) | 12 (36) | 62 (42) | ||
| FET | 64 (35) | 25 (32) | 39 (38) | 15 (45) | 49 (33) | ||
| Treatment length, yearsa | 0.28 | 0.70 | |||||
| Up to 1 | 102 (56) | 39 (50) | 63 (61) | 18 (55) | 84 (57) | ||
| 1–2 | 40 (22) | 21 (27) | 19 (18) | 9 (27) | 31 (21) | ||
| >2 | 39 (22) | 18 (23) | 21 (20) | 6 (18) | 33 (22) | ||
| IVF cycles, na | 0.17 | 0.09 | |||||
| 0 | 32 (26) | 17 (29) | 15 (24) | 4 (17) | 28 (28) | ||
| 1–2 | 60 (49) | 24 (41) | 36 (57) | 16 (70) | 44 (44) | ||
| ≥3 | 30 (25) | 18 (31) | 12 (19) | 3 (13) | 27 (27) | ||
| Total | 122 (100) | ||||||
| COVID-19-related variables | |||||||
| Currently workinga | 0.10 | 0.09 | |||||
| Yes | 146 (81) | 63 (81) | 83 (81) | 23 (70) | 123 (83) | ||
| No, laid off | 16 (9) | 7 (9.0) | 9 (9) | 3 (9) | 13 (9) | ||
| No, not working before | 19 (10) | 8 (10) | 11 (11) | 7 (21) | 12 (8) | ||
| Any anticipated income lossa | 0.69 | 0.99 | |||||
| Yes | 99 (55) | 44 (56) | 55 (53) | 18 (55) | 81 (55) | ||
| No | 82 (45) | 34 (44) | 48 (47) | 15 (45) | 67 (45) | ||
| COVID-19 anxiety scale, mean (SD)b | 2.74 (0.90) | 2.45(0.84) | 2.95 (0.88) | <0.001 | 3.30 (0.79) | 2.61 (0.87) | <0.001 |
| COVID-19 social support scale, mean (SD)b | 3.38 (0.81) | 3.21 (0.83) | 3.52 (0.77) | 0.009 | 3.65 (0.70) | 3.32 (0.82) | 0.03 |
Percentages have been rounded and may not total to 100%.
a
Chi-squared test.
b
t-test.
CAD, Canadian dollar; CFAS, Canadian Fertility and Andrology Society; FET, frozen embryo transfer; IUI, intrauterine insemination.